Sputnik V will be manufactured in China

The Russian Direct Investment Fund has approved the production of more than 60 million doses of Sputnik V vaccine in China. Production is scheduled to begin in May this year.

“RDIF and one of China’s leading biotech companies, Shenzhen Yuanxing Gene-tech Co. announced an agreement to produce more than 60 million doses of the world’s first registered Sputnik V coronavirus vaccine”, the Foundation said.

The volume produced will ensure the vaccination of over 30 million people. The start of commercial production is scheduled for May this year.


comments powered by HyperComments